Year None2024202320222021202020192018 3/25/24 AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases 3/21/24 Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results 1/8/24 Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation
3/25/24 AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
3/21/24 Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
1/8/24 Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation
